Search Results
Jun 02, 2026, 10:23 ET Stelexis BioSciences Announces Positive Phase 1 Data for Eganelisib in Relapsed/Refractory AML and Higher-Risk MDS in an Oral Presentation at ASCO 2026
low-grade with no Grade 5 related AEs. Of note, no eganelisib-related SAEs were observed and no patient discontinued treatment due to an eganelisib-related AE.Published outcomes for patients with relapsed/refractory disease who failed frontline venetoclax and hypomethylating agent therapy have shown a
More news about: Stelexis BioSciences, Inc.
Jun 02, 2026, 07:35 ET LG Transforms Home Viewing Across the Middle East and Africa with Ultimate Football Season Campaign Featuring Wael Gomaa and Hafid Derradji
TVs, please visit https://www.lg.com/ae/tvs-soundbars/webos-for-entertainment.About webOS platformThe webOS platform has powered LG TVs for over a decade, earning acclaim for its
More news about: LG
Jun 02, 2026, 07:31 ET LG Transforms Home Viewing Across the Middle East and Africa with Ultimate Football Season Campaign Featuring Wael Gomaa and Hafid Derradji
TVs, please visit https://www.lg.com/ae/tvs-soundbars/webos-for-entertainment.About webOS platformThe webOS platform has powered LG TVs for over a decade, earning acclaim for its
More news about: LG
May 31, 2026, 20:00 ET 圖睿科技將於 COMPUTEX 2026 展出 AI-ready 全系列 RAID 儲存解決方案
Cache Offloading 作為展出主軸，聚焦大型語言模型在長上下文、多輪對話與多使用者推論情境下，對高速資料存取與記憶體管理的迫切需求。針對不同 AI 部署場景，圖睿科技將展示兩大核心解決方案：SupremeRAID™ AE 與 SupremeRAID™ HE。SupremeRAID™ AE 專為企業 AI 與 GPU 伺服器打造，透過既有 GPU 資源加速 NVMe RAID，提升 AI 推論與 KV Cache 存取效能，並可實現 TTFT 最高 4 倍提升，協助企業以更低延遲回應 AI 應用需求。SupremeRAID™
More news about: 圖睿科技
May 31, 2026, 17:36 ET Servier to Present Extended Follow-Up Results from the Phase 3 INDIGO Trial Showing Durable and Sustained Treatment Benefits of VORANIGO® (vorasidenib) at ASCO 2026
gamma-glutamyltransferase (3%) and syncope (1.8%). No new safety signals were detected and fewer than 5% of patients discontinued treatment due to an AE. There were no treatment-related deaths."Historically, many patients with Grade 2 IDH-mutant gliomas faced a poor long-term prognosis and
More news about: Servier Pharmaceuticals
May 29, 2026, 08:00 ET AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
primarily grade 1 or 2 in severity. The most common grade 3/4 AEs were neutropenia (33%), hypertension (6%) and neutrophil count decreased (5%). One fatal AE (sudden death) occurred during ibrutinib lead-in. Serious AEs occurred in 36 patients (23%).About VENCLYXTO VENCLYXTO® (venetoclax)
More news about: AbbVie
May 29, 2026, 08:00 ET AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
primarily grade 1 or 2 in severity. The most common grade 3/4 AEs were neutropenia (33%), hypertension (6%) and neutrophil count decreased (5%). One fatal AE (sudden death) occurred during ibrutinib lead-in. Serious AEs occurred in 36 patients (23%).About VENCLYXTO VENCLYXTO® (venetoclax)
More news about: AbbVie
May 29, 2026, 02:27 ET Paratus Energy: Q1 2026 Results
https://mb.cision.com/Public/21459/4354928/ae3d59d615a003d2.pdfQ1 2026 Interim Results
More news about: Paratus Energy Services Ltd
May 29, 2026, 02:22 ET Paratus Energy: Q1 2026 Results
https://mb.cision.com/Public/21459/4354928/ae3d59d615a003d2.pdfQ1 2026 Interim
More news about: Paratus Energy Services Ltd
May 27, 2026, 07:00 ET Warner Bros. Discovery Announces Receipt of Requisite Consents for Proposed Amendments in Consent Solicitations
US55903VAJ26 U55632 AE0 USU55632AE07$1,436,131,000
More news about: Warner Bros. Discovery, Inc.
May 27, 2026, 06:45 ET Kennametal Inc. Announces Final Results and Expiration of Cash Tender Offer for Debt Securities
due 2028489170AE0$300,000,000
More news about: Kennametal Inc.
May 26, 2026, 15:25 ET Kennametal Inc. Announces Pricing Terms of Cash Tender Offer for Debt Securities
due 2028489170AE0$300,000,000
More news about: Kennametal Inc.
May 26, 2026, 07:30 ET Biohaven Reports New Clinical Data in Epilepsy with Opakalim, a Selective Kv7.2/7.3 Activator, Highlighting Seizure Control and Markedly Differentiated Tolerability Profile
control with a substantially lower burden of CNS AEs, including markedly lower rates of dizziness, somnolence, fatigue, and memory impairment.The AE profile was favorable and consistent with prior data, with a markedly lower incidence of AEs compared to approved and investigational ASMs (Figure
More news about: Biohaven Ltd.
May 22, 2026, 11:39 ET Synergis Software abre a Adept Experience 2026 com o maior lançamento de produto da história da empresa
https://mma.prnewswire.com/media/2983911/Synergis_Software_AE26___Cover_Image.jpgFoto -
More news about: Synergis Software
May 22, 2026, 11:37 ET Synergis Software inaugura Adept Experience 2026 con el mayor lanzamiento de productos en la historia de la empresa
https://mma.prnewswire.com/media/2983911/Synergis_Software_AE26___Cover_Image.jpgFoto -
More news about: Synergis Software
May 22, 2026, 04:02 ET Synergis Software inaugure Adept Experience 2026 avec le plus grand lancement de produits de l'histoire de l'entreprise
https://mma.prnewswire.com/media/2983911/Synergis_Software_AE26___Cover_Image.jpgPhoto -
More news about: Synergis Software
May 22, 2026, 00:01 ET Unison Hardware Supports Milestone First Flight of Unmanned U.S. Navy MQ-25A
the first flight of the U.S. Navy MQ-25A Stingray™ unmanned aircraft, a major milestone achieved on April 25. The aircraft, powered by the Rolls-Royce AE 3007N engine, incorporates several systems designed and manufactured by Unison.
More news about: Unison, a GE Aerospace company
May 21, 2026, 17:00 ET Boehringer Ingelheim's oncology portfolio shows strong promise across multiple cancers at ASCO 2026
profiles of the individual agents, with grade ≥3 AEs primarily related to chemotherapy. Cytokine release syndrome was the most common obrixtamig-related AE (57%).5Discontinuations due to obrixtamig‑related AEs were infrequent (n=1).5"Given the longstanding need
More news about: Boehringer Ingelheim
May 20, 2026, 21:00 ET SOFIRN Launches SE1, A Quick-Release Pocket Light for On-the-Spot Tasks
https://store.us.sofirnlight.com/US-SE1-ALGlobal Store: https://tinyurl.com/GLOBAL-AE1-ALAbout SOFIRNFounded in 2016, SOFIRN creates lighting tools focused on what matters most: practical use, consistent
More news about: SOFIRN
May 20, 2026, 20:01 ET Synergis Software eröffnet die Adept Experience 2026 mit der größten Produkteinführung in der Unternehmensgeschichte
https://mma.prnewswire.com/media/2983911/Synergis_Software_AE26___Cover_Image.jpgFoto -
More news about: Synergis Software
May 20, 2026, 10:43 ET Synergis Software inaugura Adept Experience 2026
https://mma.prnewswire.com/media/2983911/Synergis_Software_AE26___Cover_Image.jpgFoto -
More news about: Synergis Software
May 20, 2026, 10:03 ET Artificial Epistemics Declares AI Safety & Alignment Problems Solved in Principle
WOODSTOCK, Vt., May 20, 2026 /PRNewswire/ -- Artificial Epistemics, LLC (AE) announced today that it has effectively solved the
More news about: Artificial Epistemics, LLC
May 20, 2026, 06:46 ET LG Aligns with UAE's Energy Conservation Goals, Championing Efficient Cooling Solutions
energy-efficient air conditioners, visit https://www.lg.com/ae/tropical-split-air-conditioners About LG Electronics Eco Solution Company The LG Eco Solution Company
More news about: LG
May 20, 2026, 06:45 ET Canon Demonstrates Print's 'Power to Move' With On-Stand Experience and Latest Large Format Technologies at FESPA Global Print Expo 2026
multimedia:https://www.prnewswire.com/ae/news-releases/canon-demonstrates-prints-power-to-move-with-on-stand-experience-and-latest-large-format-technologies-at-fespa-global-print-expo-2026-302777540.html
More news about: Canon Middle East
May 20, 2026, 04:02 ET Synergis Software Opens Adept Experience 2026 With the Largest Product Launch in Company History
https://mma.prnewswire.com/media/2983911/Synergis_Software_AE26___Cover_Image.jpgPhoto -
More news about: Synergis Software